Sale!

TP63 Gene Limb-Mammary Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TP63 Gene Limb-Mammary Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TP63 gene that are associated with Limb-Mammary Syndrome (LMS). This condition is a rare genetic disorder characterized by limb malformations, ectodermal dysplasia, and in some cases, mammary gland anomalies. The TP63 gene plays a critical role in the development and differentiation of tissues and organs during embryonic development, and mutations in this gene can lead to the clinical manifestations observed in LMS.

The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TP63 gene that are known to cause Limb-Mammary Syndrome. It is a crucial tool for clinicians in diagnosing the syndrome, enabling them to provide appropriate genetic counseling to affected families, and to guide treatment and management decisions for individuals with the condition.

The cost of the TP63 Gene Limb-Mammary Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, which includes not only the genetic analysis but also post-test counseling and support. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and counselors, ensuring high-quality testing and reliable results for patients and their families seeking answers about Limb-Mammary Syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TP63 Gene Limb-mammary syndrome Genetic Test

Are you looking for a reliable genetic lab in UAE to perform the TP63 Gene Limb-mammary syndrome Genetic Test? Look no further than DNA Labs UAE. We offer comprehensive genetic testing services, including the TP63 Gene Limb-mammary syndrome Genetic Test, at an affordable cost of AED 4400.0.

Test Components

  • Test Name: TP63 Gene Limb-mammary syndrome Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test gene TP63.

Test Details

The TP63 gene plays a crucial role in the development and maintenance of various tissues in the body, including the limbs and mammary glands. Limb-mammary syndrome is a rare genetic disorder caused by mutations in the TP63 gene. This condition is characterized by abnormalities in the limbs, such as missing fingers or toes, and abnormal development of the mammary glands, leading to underdeveloped or absent breasts.

Our TP63 Gene Limb-mammary syndrome Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes, including the TP63 gene. By analyzing a blood or saliva sample, this test can identify mutations or changes in the TP63 gene that may be associated with limb-mammary syndrome.

During the test, the DNA in the sample is sequenced, and the data is analyzed to identify any mutations or changes in the TP63 gene. This information can help confirm a diagnosis of limb-mammary syndrome and provide valuable insights into the specific mutation or change in the TP63 gene. It can assist in determining the prognosis, treatment options, and recurrence risk for affected individuals and their families.

If you suspect limb-mammary syndrome or have a family history of the condition, it is crucial to undergo the TP63 Gene Limb-mammary syndrome Genetic Test. Early detection and diagnosis can make a significant difference in managing the condition and providing appropriate care.

At DNA Labs UAE, we are committed to delivering accurate and reliable genetic testing services. Contact us today to schedule your TP63 Gene Limb-mammary syndrome Genetic Test and take a step towards better health.

Test Name TP63 Gene Limb-mammary syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test gene TP63
Test Details

The TP63 gene is a gene that provides instructions for making a protein called p63. This protein is involved in the development and maintenance of many different tissues in the body, including the limbs and mammary glands.

Limb-mammary syndrome is a rare genetic disorder caused by mutations in the TP63 gene. This condition is characterized by abnormalities in the limbs, such as missing fingers or toes, and abnormal development of the mammary glands, which can lead to underdeveloped or absent breasts.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the TP63 gene. This test can identify mutations or changes in the TP63 gene that may be associated with limb-mammary syndrome.

NGS genetic testing is typically performed using a blood or saliva sample. The DNA in the sample is sequenced, and the data is analyzed to identify any mutations or changes in the TP63 gene.

This type of genetic testing can help confirm a diagnosis of limb-mammary syndrome and provide information about the specific mutation or change in the TP63 gene. This information can be useful for determining the prognosis, treatment options, and recurrence risk for affected individuals and their families.